BRIEF published on 09/26/2024 at 12:35, 1 month 24 days ago SCHOTT Pharma, Gerresheimer et le groupe Stevanato forment une « alliance pour la RTU » Efficacité Pharmaceutique Confinement Des Drogues Alliance RTU Risque Opérationnel Emballage Stérile
BRIEF published on 09/26/2024 at 12:35, 1 month 24 days ago SCHOTT Pharma, Gerresheimer, and Stevanato Group Form “Alliance for RTU” Drug Containment Pharmaceutical Efficiency RTU Alliance Operational Risk Sterile Packaging
PRESS RELEASE published on 09/26/2024 at 12:30, 1 month 24 days ago SCHOTT Pharma, Gerresheimer, and Stevanato Group announce strategic industry “Alliance for RTU” SCHOTT Pharma, Gerresheimer, and Stevanato Group form Alliance for RTU, advancing ready-to-use containers for pharmaceutical manufacturing efficiency and patient safety SCHOTT Pharma Gerresheimer Pharmaceutical Manufacturing Stevanato Group Alliance For RTU
BRIEF published on 09/05/2024 at 07:05, 2 months 16 days ago SCHOTT Pharma cotée au MDAX pour la première fois Bourse De Francfort Objectifs De Croissance Confiance Du Marché Inclusion MDAX Confinement Des Drogues
BRIEF published on 09/05/2024 at 07:05, 2 months 16 days ago SCHOTT Pharma Listed on MDAX for the First Time Frankfurt Stock Exchange Growth Targets Market Confidence MDAX Inclusion Drug Containment
PRESS RELEASE published on 09/05/2024 at 07:00, 2 months 16 days ago Promotion for SCHOTT Pharma: Listed on the MDAX for the first time SCHOTT Pharma AG & Co. KGaA to be included in the MDAX index, marking a significant milestone. Company continues to expand and strengthen market position Market Position SCHOTT Pharma Growth Targets MDAX Share Listing
BRIEF published on 08/29/2024 at 07:05, 2 months 23 days ago SCHOTT Pharma Delivers Strong Third Quarter Results and Raises FY 2024 Revenue Guidance Innovation Revenue Growth EBITDA Margin High-value Solutions Expansion Projects
BRIEF published on 08/29/2024 at 07:05, 2 months 23 days ago SCHOTT Pharma publie de solides résultats au troisième trimestre et relève ses prévisions de chiffre d'affaires pour l'exercice 2024 Innovation Croissance Des Revenus Marge D'EBITDA Des Solutions À Forte Valeur Ajoutée Projets D'agrandissement
PRESS RELEASE published on 08/29/2024 at 07:00, 2 months 23 days ago SCHOTT Pharma delivers strong third quarter results and raises FY 2024 revenue guidance SCHOTT Pharma reports strong Q3 results with 21% revenue growth, EBITDA margin of 28.2%, and raises FY 2024 revenue guidance. Strategic focus on innovation and growth projects Innovation Revenue Growth FY 2024 Guidance SCHOTT Pharma Q3 Results
BRIEF published on 08/08/2024 at 16:25, 3 months 12 days ago SCHOTT Pharma Aligns Climate Actions with Paris Agreement Goals Decarbonization Climate Action Green Electricity GHG Emissions Paris Agreement
Published on 11/21/2024 at 09:00, 48 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 13 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 23 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 48 minutes ago Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 48 minutes ago Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates
Published on 11/21/2024 at 08:59, 48 minutes ago Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 48 minutes ago Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 32 minutes ago EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.
Published on 11/21/2024 at 08:09, 1 hour 38 minutes ago KAP HOLDS ITS GROUND IN A DIFFICULT INDUSTRY ENVIRONMENT IN THE FIRST NINE MONTHS OF 2024
Published on 11/21/2024 at 06:58, 2 hours 50 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 50 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 50 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 40 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 27 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting